Age-Related Eye Disease Study Research Group. 2001. A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss. Arch Ophthalmol, 119:1417–36. Bhutto IA, McLeod DS, Hasegawa T, et al. 2006. Pigment epithelium-derived factor (PEDF) and vascular endothelial growth factor (VEGF) in aged human choroid and eyes with age-related macular degeneration. Exp Eye Res, 82:99–110. Bird JC, Marshall J. 1986. Retinal pigment epithelial detachments in the elderly. Trans Soc Ophthalmol UK, 105:674–82. Boehm AG, Koeller AU, Pillunat LE. 2005. The effect of age on optic nerve head blood ﬂow. Invest Ophthalmol Vis Sci, 46:1291–5. Bressler NM, Bressler SB, Fine SL 1988. Age-related macular degeneration. Surv Ophthalmol, 32:375–413. Bressler S, Maguire G, Bressler N, et al. 1990. Relationship of dru- sen and abnormalities of the retinal pigment epithelium to the prognosis of neovascular macular degeneration. Arch Ophthalmol, 108:1442–7. Burns RP, Feeney-Burns L. 1980. Clinico-morphologic correlations of drusen of Bruch’s membrane. Trans Am Ophthalmol Soc, 78:206–25. Cai J, Wu M, Nelson KC, et al. 1999. Oxidant-induced apoptosis in cultured human retinal pigment epithelial cells. Invest Ophthalmol Vis Sci, 40:959–66. Chen SJ, Cheng CY, Lee AF, et al. 2001. Pulsatile ocular blood ﬂow in asymmetric exudative age related macular degeneration. Br J Ophthalmol, 85:411–15. Ciulla TA, Harris A, Chung HS, et al. 1999. Color Doppler imaging discloses reduced ocular blood ﬂow velocities in nonexudative age-related macu- lar degeneration. Am J Ophthalmol, 128:75–80. Ciulla TA, Harris A, Martin BJ. 2001. Ocular perfusion and age related macular degeneration. Acta Ophthalmol Scand, 79:108–15. Ciulla TA, Harris A, Kagemann L, et al. 2002. Choroidal perfusion per- turbations in non-neovascular age related macular degeneration. Br J Ophthalmol, 86:209–13. Crabb JW, Miyagi M, Gu X, et al. 2002. Drusen proteome analysis: an approach to the etiology of age-related macular degeneration. Proc Natl Acad Sci USA, 99:14682–7. Curcio CA, Millican CL, Bailey T, et al. 2001. Accumulation of cholesterol with age in human Bruch’s membrane. Invest Ophthalmol Vis Sci, 42:265–74. de Jong PT. 2006. Age related macular degeneration. N Engl J Med, 355:1474–85. Del Priore LV, Kaplan HJ, Hornbeck R, et al. 1996. Retinal pigment epithelial debridement as a model for the pathogenesis and treatment of macular degeneration. Am J Ophthalmol, 122:629–43. Dimitrova G, Tamaki Y, Kato S. 2002. Retrobulbar circulation in patients with age-related maculopathy. Eye, 16:580–6. Embleton SJ, Hosking SL, Roff Hilton EJ, et al. 2002. Effect of senescence on ocular blood ﬂow in the retina, neuroretinal rim and lamina cribrosa, using scanning laser Doppler ﬂowmetry. Eye, 16:156–62. Feeney-Burns L, Ellersieck MR. 1985. Age-related changes in the ultrastruc- ture of Bruch’s membrane. Am J Ophthalmol, 100:686–97. Feeney-Burns L, Hilderbrand ES, Eldridge S. 1984. Aging human RPE: morphometric analysis of macular, equatorial and peripheral cells. Invest Ophthalmol Vis Sci, 25:195–200. Fine SL, Berger JW, Maguire MG, et al. 2000. Age-related macular degen- eration. N Engl J Med, 342:483–92. Fitzgerald MEC, Tolley E, Jackson B, et al. 2005. Anatomical and func- tional evidence for progressive age-related decline in parasympathetic control of choroidal blood ﬂow in pigeons. Experimental Eye Research, 81:478–91. Friedman E, Ivry M, Ebert E, et al. 1989. Increased scleral rigidity and age- related macular degeneration. Ophthalmology, 96:104–8. Friedman E, Krupsky S, Lane AM, et al. 1995. Ocular blood ﬂow velocity in age-related macular degeneration. Ophthalmology, 102:640–6. Friedman E. 1997. A hemodynamic model of the pathogenesis of age related macular degeneration. Am J Ophthalmol, 124:677–82. Clinical Interventions in Aging 2008:3(3) AMD of the aging eye Friedman E. 2000. The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration. Am J Ophthalmol, 130:658–63. Friedman E. 2004. Update of the vascular model of AMD. Br J Ophthalmol, 88:161–3. Gold B, Merriam JE, Zernant J, et al. 2006. Variation in factor B (FB) and complement 2 (C2) genes is associated with age related macular degeneration. Nat Genet, 38:458–62. Gotoh N, Yamada R, Hiratani H, et al. 2006. No association between complement H gene polymorphism and exudative age related macular degeneration in Japanese. Hum Genet,120:1–5. Grizzard SW, Arnett D, Haag SL. 2003. Twin study of age related macular degeneration. Ophthalmic Epidemiol, 10:315–22. Groh MJ, Michelson G, Langhans MJ, et al. 1996. Inﬂuence of age on retinal and optic nerve head blood circulation. Ophthalmology, 103:529–34. Grunwald JE, Hariparasad SM, DuPont J, et al. 1998. Effect of aging on foveolar choroidal circulation. Arch Ophthalmol, 116:150–4. Grunwald JE, Metelitsina TI, Dupont JC, et al. 2005. Reduced foveolar blood ﬂow in eyes with increased AMD severity. Invest Ophthalmol Vis Sci, 46:1033–8. Harris A, Harris M, Biller J, et al. 2000. Aging affects the retrobulbar circula- tion differently in women and men. Arch Ophthalmol, 118:1076–80. Henkind P, Gartner S. 1983. The relationship between retinal pigment epithe- lium and the choriocapillaris. Trans Ophthalmol Soc UK, 103:444–7. Hogg RE, Woodside JV, Gilchrist SE, et al. 2007. Cardiovascular disease and hypertension are strong risk factors for choroidal neovascularization. Ophthalmology, 115:1046–52. Holekamp NM, Bouck N, Volpert O. 2002. Pigment epithelium-derived factor is deﬁcient in the vitreous of patients with choroidal neovascu- larization due to age-related macular degeneration. Am J Ophthalmol, 134:220–7. Hershko A, Ciechanover A. 1998. The ubiquitin system. Annu Rev Biochem, 67:425–79. Hosal BM, Karakoç G, Gürsel E, et al. 1998. Color Doppler imaging of the retrobulbar circulation in age-related macular degeneration. Eur J Ophthalmol, 8:234–8. Hyman L, Schachat AP, He Q, Leske MC. 2000. Hypertension, cardiovascular disease, and age-related macular degeneration. Age-Related Macular Degeneration Risk Factors Study Group. Arch Ophthalmol, 118:351–8. Hyman L, Neborsky R. 2002. Risk factors for age-related macular degenera- tion: an update. Curr Opin Ophthalmol, 13:171–5. Klaver CC, Wolfs RC, Assink JJ, et al. 1998. Genetic risk of age related maculopathy. Population-based familial aggregation study. Arch Oph- thalmol, 116:1646–51. Klein R, Klein BE, Jensen SC, et al. 1997. The ﬁve years incidence and progression of age related maculopathy: the Beaver Dam Eye Study. Ophthalmology, 104:7–21. Klein R, Klein BE, Cruickshanks KJ. 1999. The prevalence of age related maculopathy by geographic region and ethnicity. Prog Retin Eye Res, 18:371–89. Klein R, Klein BE, Tomany SC, et al. 2003. The association of cardiovascular disease with the long-term incidence of age-related maculopathy: the Beaver Dam Eye Study. Ophthalmology, 110:273–80. Klein R, Klein BE, Knudtson MD, et al. 2006. Prevalence of age related macular degeneration in 4 racial/ethnic groups in the multi-ethnic study of atherosclerosis. Ophthalmology, 113:373–80. Klein R, Klein BE, Knudtson MD, et al. 2007a. Subclinical atherosclerotic cardiovascular disease and early age-related macular degeneration in a multiracial cohort: the Multiethnic Study of Atherosclerosis. Arch Ophthalmol, 125:534–43. Klein R, Deng Y, Klein BE, et al. 2007b. Cardiovascular disease, its risk factors and treatment, and age-related macular degeneration: Women’s Health Initiative Sight Exam ancillary study. Am J Ophthalmol, 143:473–83. Lam AKC, Chan ST, Chan H, et al. 2003. The effect of age on ocular blood supply determined by pulsatile ocular blood ﬂow and color Doppler ultrasonography. Optom Vis Sci, 80:305–11. 481